GV20 Therapeutics to Present at the Jefferies Healthcare Conference Private Biotech Day

/PRNewswire/ -- GV20 Therapeutics, a clinical-stage biotechnology company integrating AI, genomics, and disease biology to create next-generation antibody...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,New York ,United States ,Amy Conrad ,Ying Gong ,Linkedin ,Simultaneous Target Evaluation ,Antibody Discovery ,Fc Attenuated Igg ,